Business

July 25, 2014 4:57 PM

RTP pharma company receives FDA fast-track status

The Food and Drug Administration has given fast-track status to a treatment called HumaGraft being developed by Humacyte, a Research Triangle Park pharmaceutical company.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs